![Cécile Bougeret](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Cécile Bougeret
Director de Operaciones en Diaccurate SA .
Cargos activos de Cécile Bougeret
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Diaccurate SA
![]() Diaccurate SA Medical SpecialtiesHealth Technology Diaccurate SASU engages in the research of diagnostic products. It offers diagnostic products especially in the field of theranostics. The firm operates as a biopharmaceutical company that engages in developing new therapies for the treatment of HIV infection. The company was founded in 2012 and is headquartered in Paris, France. | Director de Operaciones | 01/12/2020 | - |
Historial de carrera de Cécile Bougeret
Antiguos cargos conocidos de Cécile Bougeret.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Cytomics Pharmaceuticals SA
![]() Cytomics Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Cytomics Pharmaceuticals is a biopharmaceutical company dedicated to discovering and developing drugs that control the degradation of proteins, to treat major human diseases. The company was founded in April 2000 in collaboration with Dominique Thomas (Research Director at the Center for Molecular Genetics of the CNRS) and Richard Benarous (Director of the Department for Infectious Diseases 'at the Cochin Institute of Molecular Genetics), both specialists recognized by the ubiquitin-proteasome protein degradation. | Director de Operaciones | - | 10/10/2011 |
Biokinesis SAS
![]() Biokinesis SAS BiotechnologyHealth Technology Biokinesis SAS provides research and development services. The firm specializes in Oncology. The company was founded in October 2011 and is headquartered in Paris, France. | Director Ejecutivo | - | - |
Diatos SA
![]() Diatos SA Pharmaceuticals: MajorHealth Technology Diatos SA develops innovative therapies for the treatment of cancer. The firm leverages its peptide-based, intracellular drug delivery & tumor targeting technologies to improve the properties of existing therapeutics. Its products include DaunoXome, DTS-301 and DTS-108. The company was founded in 1999 and headquartered in Paris, France. | Corporate Officer/Principal | - | - |
Aventis, Inc. | Corporate Officer/Principal | - | - |
Formación de Cécile Bougeret.
Harvard University | Doctorate Degree |
The Rockefeller University | Doctorate Degree |
Estadísticas
Internacional
Francia | 6 |
Estados Unidos | 4 |
Operativa
Doctorate Degree | 3 |
Chief Operating Officer | 2 |
Corporate Officer/Principal | 2 |
Sectorial
Health Technology | 5 |
Consumer Services | 4 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 6 |
---|---|
Cytomics Pharmaceuticals SA
![]() Cytomics Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Cytomics Pharmaceuticals is a biopharmaceutical company dedicated to discovering and developing drugs that control the degradation of proteins, to treat major human diseases. The company was founded in April 2000 in collaboration with Dominique Thomas (Research Director at the Center for Molecular Genetics of the CNRS) and Richard Benarous (Director of the Department for Infectious Diseases 'at the Cochin Institute of Molecular Genetics), both specialists recognized by the ubiquitin-proteasome protein degradation. | Health Technology |
Université Paris Diderot-Paris 7 | Consumer Services |
Aventis, Inc. | |
Diatos SA
![]() Diatos SA Pharmaceuticals: MajorHealth Technology Diatos SA develops innovative therapies for the treatment of cancer. The firm leverages its peptide-based, intracellular drug delivery & tumor targeting technologies to improve the properties of existing therapeutics. Its products include DaunoXome, DTS-301 and DTS-108. The company was founded in 1999 and headquartered in Paris, France. | Health Technology |
Biokinesis SAS
![]() Biokinesis SAS BiotechnologyHealth Technology Biokinesis SAS provides research and development services. The firm specializes in Oncology. The company was founded in October 2011 and is headquartered in Paris, France. | Health Technology |
Diaccurate SA
![]() Diaccurate SA Medical SpecialtiesHealth Technology Diaccurate SASU engages in the research of diagnostic products. It offers diagnostic products especially in the field of theranostics. The firm operates as a biopharmaceutical company that engages in developing new therapies for the treatment of HIV infection. The company was founded in 2012 and is headquartered in Paris, France. | Health Technology |
- Bolsa de valores
- Insiders
- Cécile Bougeret
- Experiencia